Professor Michele Faulkner, PharmD, collaborated with the biopharmaceutical company UCB to create a medical platform for patients and caregivers with epilepsy.
With other epilepsy experts from around the country, Faulkner, the only non-physician invited to take part in the project, developed a part of the platform to provide real world patient cases to help clinicians make decisions and appropriately utilize antiepileptic therapy. View the UCB website.
